Nonseminomatous germ cell tumour of testis in Hong Kong Chinese patients.
Combination chemotherapy with multidisciplinary support results in excellent cure rate for nonseminomatous germ cell tumour of testis. 52 Chinese patients treated in two institutions in Hong Kong were reviewed retrospectively. 29 patients were stage I and IM and 3-year survival was 96% with a median follow-up of 49 months. 23 patients were stage II and above and 3-year survival was 54% with a median follow-up of 21 months. The patient details are compared with a Western population, factors influencing outcome are discussed, and provision of optimal care outlined.
Chan
A T
AT
Department of Clinical Oncology, Chinese University of Hong Kong.
Cheung
M C
MC
Lau
W H
WH
Lin
J
J
Yeo
W
W
Johnson
P J
PJ
D000328:Adult; D002681:China / Q000208:ethnology; D018237:Germinoma / Q000208:ethnology* / Q000473:pathology / Q000628:therapy; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016019:Survival Analysis; D013736:Testicular Neoplasms / Q000208:ethnology* / Q000473:pathology / Q000628:therapy; D016896:Treatment Outcome